Damloran Pharmaceutical (XTEH:DAML1) Quick Ratio: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Quick Ratio?

Damloran Pharmaceutical XTEH:DAML1 27 Quick Ratio is 0.00 as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Damloran Pharmaceutical's quick ratio for the quarter that ended in . 20 was 0.00.

Damloran Pharmaceutical has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Damloran Pharmaceutical's Quick Ratio or its related term are showing as below:

XTEH:DAML1's Quick Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.45
* Ranked among companies with meaningful Quick Ratio only.

Damloran Pharmaceutical  (XTEH:DAML1) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Damloran Pharmaceutical Quick Ratio Related Terms

Damloran Pharmaceutical Quick Ratio Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Quick Ratio Chart

Damloran Pharmaceutical Annual Data
Trend
Quick Ratio

Damloran Pharmaceutical Semi-Annual Data
Quick Ratio

XTEH:DAML1 vs IMNPQ: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Damloran Pharmaceutical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Damloran Pharmaceutical Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Damloran Pharmaceutical's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Damloran Pharmaceutical's Quick Ratio falls into.


XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Damloran Pharmaceutical's Quick Ratio for the fiscal year that ended in . 20 is calculated as

Quick Ratio (A: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

Damloran Pharmaceutical's Quick Ratio for the quarter that ended in . 20 is calculated as

Quick Ratio (Q: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.00 mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Quick Ratio of 0.00 as of . 20. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's Quick Ratio too high?
Damloran Pharmaceutical's current Quick Ratio is 0.00. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Quick Ratio compare to IMNPQ?
Damloran Pharmaceutical's Quick Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Quick Ratio is 1.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Damloran Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Damloran Pharmaceutical's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Quick Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price